Mid-Year Report

TARPLIN, DOWNS & YOUNG, LLC for WYETH

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

S. 3/H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicare Part D "Non-Interference" Proposals S. 250 - Medicare Enhancements for Needed Drugs Act of 2007 ***, no specific bill(s), Medicare and Medicaid Drug Reimbursement Medicare and Medicaid Drug Reimbursement H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S. 1893 - Children's Health Insurance Program Reauthorization Act of 2007

LobbyistCovered position, as disclosed
RAISSA H DOWNS N/A
ISAAC A FORDJOUR N/A
LINDA E TARPLIN N/A
JENNIFER B YOUNG ASSISTANT SECRETARY FOR LEGISLATION, HHS

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; White House Office

Bills named: H.R. 4 (110th), S. 3 (110th), S. 1893 (110th), S. 250 (110th), H.R. 3162 (110th)

Budget/Appropriations BUD

FDA Appropriations Critical Path Drug Safety Human Drug Review H. Con. Res. 99/S. Con. Res. 21 - Budget Resolution, Medicare and Medicaid Drug Reimbursement

LobbyistCovered position, as disclosed
RAISSA H DOWNS N/A
ISAAC A FORDJOUR N/A
LINDA E TARPLIN N/A
JENNIFER B YOUNG ASSISTANT SECRETARY FOR LEGISLATION, HHS

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 21 (110th), H.Con.Res. 99 (110th)

Health Issues HCR

***, no specific bill(s), Alzheimers Research, Hormone Replacement Therapy

LobbyistCovered position, as disclosed
RAISSA H DOWNS N/A
ISAAC A FORDJOUR N/A
LINDA E TARPLIN N/A
JENNIFER B YOUNG ASSISTANT SECRETARY FOR LEGISLATION, HHS

Contacted: White House Office; SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Drug Safety S. 1082 - Prescription Drug User Fee Amendments of 2007 H.R. 2900 - Food and Drug Administration Amendments of 2007 Follow-on Biologics H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/H.R. 1038 - Access to Life-Saving Medicine Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 S. 1505 - Affordable Biologics for Consumers Act ***, no specific bill(s), Follow-On Biologics, Drug Safety, PDUFA Reauthorization *** see addendum page

LobbyistCovered position, as disclosed
RAISSA H DOWNS N/A
ISAAC A FORDJOUR N/A
LINDA E TARPLIN N/A
JENNIFER B YOUNG ASSISTANT SECRETARY FOR LEGISLATION, HHS

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1038 (110th), S. 623 (110th), H.R. 1956 (110th), S. 1505 (110th), H.R. 2900 (110th), S. 1695 (110th), S. 1082 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.